Live feed09:05:54·1293dNEWSReleasevia QuantisnowOculis SA And European Biotech Acquisition Corp Announce Business Combination Agreement To Create Nasdaq-lListed BioPharmaceutical Company Driving Breakthrough Innovations In OphthalmologyByQuantisnow·Wall Street's wire, on your screen.EBAC· European Biotech Acquisition Corp.Finance